# US 2004/0082001 A1 · Method and compositions for ordering restriction fragments

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082001 A1
- Document ID: US20040082001A1
- Status: Published application
- Kind: A1
- Application number: 10/706,118
- Filed: 2003-11-12
- Published: 2004-04-29
- Earliest claimed: 1998-02-23
- Assignees: Lynx Therapeutics, Inc.
- Inventors: Stephen C. Macevicz
- Web page: https://patentgrep.com/patent/US20040082001A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/64: General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/683: involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
- C12Q 1/6841: In situ hybridisation
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6872: involving mass spectrometry
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The invention provides a method for constructing a high resolution physical map of a polynucleotide. In accordance with the invention, nucleotide sequences are determined at the ends of restriction fragments produced by a plurality of digestions with a plurality of combinations of restriction endonucleases so that a pair of nucleotide sequences is obtained for each restriction fragment. A physical map of the polynucleotide is constructed by ordering the pairs of sequences by matching the identical sequences among the pairs.

## Claims

### Claim 1

A method of mapping a polynucleotide, the method comprising the steps of:
(a) providing a plurality of populations of restriction fragments, the restriction fragments of each population having ends defined by digesting the polynucleotide with a plurality of combinations of restriction endonucleases;
(b) determining the nucleotide sequence of a portion of each end of each restriction fragment of each population so that a pair of nucleotide sequences is obtained for each restriction fragment of each population; and
(c) ordering the pairs of nucleotide sequences by matching the nucleotide sequences between pairs to form a map of the polynucleotide.

### Claim 2 (depends on 1)

The method of claim 1 wherein said step of determining said nucleotide sequence of said end of each restriction fragment includes the steps of enzymatically removing a segment of nucleotides from each said end; ligating the segment of nucleotides from each said end together to form a pair of segments, ligating a sample of pairs of segments from said plurality of populations to form one or more concatenations of pairs of segments, and sequencing the concatenations of pairs of segments.

### Claim 3 (depends on 2)

The method of claim 2 wherein said plurality of populations of restriction fragments is between 3 and 8, inclusive.

### Claim 4 (depends on 3)

The method of claim 3 wherein said combinations of restriction endonucleases used for digesting said polynucleotide consist of three restriction endonucleases selected from a set of four restriction endonucleases.

### Claim 5 (depends on 3)

The method of claim 3 wherein said combinations of restriction endonucleases used for digesting said polynucleotide consist of two restriction endonucleases selected from a set of three restriction endonucleases.

### Claim 6 (depends on 5)

The method of claim 5 wherein said steps of enzymatically removing said segments of nucleotides is carried out with one of more type IIs restriction endonucleases.

### Claim 7 (depends on 6)

The method of claim 6 wherein said segments of nucleotides consist of between 7 and 9 nucleotides.

### Claim 8

A physical map of a polynucleotide comprising an ordered series of segments of nucleotides, the segments of nucleotides being adjacent to and including recognition sites in the polynucleotide of a plurality of predetermined restriction endonucleases.

### Claim 9 (depends on 8)

The physical map of claim 8 wherein said ordered series comprises at least one hundred said segments of nucleotides and wherein said plurality of predetermined restriction endonucleases is between 2 and 6, inclusive.

### Claim 10 (depends on 9)

The physical map of claim 9 wherein said segments of nucleotides of said ordered series are separated by unsequenced regions of said restriction fragments.

### Claim 11 (depends on 10)

The physical map of claim 10 wherein said ordered series comprises at least one thousand said segments of nucleotides.

### Claim 12 (depends on 8)

The physical map of claim 8 wherein said polynucleotide is between 180 kilobases and 1 megabase in length.

### Claim 13 (depends on 8)

The physical map of claim 8 wherein said polynucleotide is a genome of a microorganism.

### Claim 14

A method of mapping a polynucleotide, the method comprising the steps of:
(a) providing a plurality of populations of restriction fragments, the restriction fragments of each population having an interior and ends defined by digesting the polynucleotide with a plurality of combinations of restriction endonucleases, and each restriction fragment being inserted into a vector;
(b) cleaving each vector to remove the interior of the restriction fragment and to leave a segment of each end of the restriction fragment in the vector;
(c) circularizing each vector so that the segments of each end of each restriction fragment are ligated together to form a pair of segments;
(d) determining the nucleotide sequences of a sample of pairs of segments to obtain a sample of pairs of nucleotide sequences; and
(e) ordering the pairs of nucleotide sequences by matching the nucleotide sequences between pairs to form a map of the polynucleotide.

### Claim 15 (depends on 14)

The method of claim 14 wherein said step of determining said nucleotide sequences of said sample of said pairs of segments includes the steps of ligating said sample of pairs of segments from said plurality of populations to form one or more concatenations of pairs of segments, and sequencing the concatenations of pairs of segments.

### Claim 16 (depends on 15)

The method of claim 15 wherein said sample includes a number of said pairs of segments large enough so that with a probability of ninety-nine percent every possible kind of pair of segments is represented in said sample.

### Claim 17 (depends on 16)

The method of claim 16 wherein said step of cleaving is carried out with one or more type IIs restriction endonucleases.

### Claim 18

A vector for cloning a fragment of DNA, the vector comprising: a first type IIs restriction site and a second type IIs restriction site such that a first type IIs restriction endonuclease recognizing the first type IIs restriction site has a cleavage site downstream from the first type IIs restriction site and such that a second type IIs restriction endonucleases recognizing the second type IIs restriction site has a cleavage site upstream from the second type IIs site.

### Claim 19 (depends on 18)

The vector of claim 18 further including a third restriction site and a fourth restriction site for accepting said fragment of DNA, the third restriction site being immediately downstream of said first type IIs restriction site such that said cleavage site of said first type IIs restriction endonuclease is downstream of the third restriction site, and the fourth restriction site being immediately upstream of said second type IIs restriction site such that said cleavage site of said second type IIs restriction endonuclease is upstream of the fourth restriction site.

### Claim 20 (depends on 19)

The vector of claim 19 further including a third type IIs restriction site and a fourth type IIs restriction site, the third type IIs restriction site being positioned upstream of said first type IIs restriction site such that a third type IIs restriction endonuclease recognizing the third type IIs restriction site has a cleavage site identical to that of said third restriction site, and the fourth type IIs restriction site being positioned downstream of said second type IIs restriction site such that a fourth type IIs restriction endonuclease recognizing the fourth type IIs restriction site has a cleavage site identical to that of said fourth restriction site.

### Claim 21

A method of analyzing gene expression in a cell or tissue, the method comprising the steps of:
(a) forming a population of cDNA molecules from mRNA of a cell or tissue;
(b) determining the nucleotide sequence of a portion of each end of each cDNA molecule of the population so that a pair of nucleotide sequences is obtained for each cDNA of the population; and
(c) tabulating the pairs of nucleotide sequences to form a frequency distribution of gene expression in the cell or tissue.

### Claim 22 (depends on 21)

The method of claim 21 wherein said step of determining said nucleotide sequence of said end of each restriction fragment includes the steps of enzymatically removing a segment of nucleotides from each said end; ligating the segment of nucleotides from each said end together to form a pair of segments, ligating a sample of pairs of segments from said population of cDNA molecules to form one or more concatenations of pairs of segments, and sequencing the concatenations of pairs of segments.
